David Krempa

ETON

David Krempa serves as Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$641.1K

Net Position

Net Seller

$641.1K

Companies Traded

ETON

Active Period

Jun 2025 – Jan 2026

3 total trades

Most Recent

Sell ETON

Jan 12, 2026 · $30.3K

David Krempa's Insider Trading at Eton Pharmaceuticals, Inc. (ETON)

Buys

0 · $0.00

Sells

3 · $641.1K

Total Shares Bought

Total Shares Sold

42,206

ETON Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 12, 2026↗	Sell	1,942	$15.62	$30.3K
Dec 11, 2025↗	Sell	6,264	$17.00	$106.5K
Jun 12, 2025↗	Sell	34,000	$14.83	$504.3K

Related Insiders

RIEDEL NORBERT G

Director

ETONSell · Feb 3, 2026

James R. Gruber

Chief Financial Officer

ETONSell · Jan 14, 2026

BRYNJELSEN SEAN

President & CEO

ETONSell · Jan 1, 2026

Ipek Erdogan-Trinkaus

Chief Commercial Officer

ETONSell · Dec 12, 2025

Explore More Insider Trading Data

ETON Insider Trading Activity

View all insider trades at Eton Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity